Reply by Authors.
Saved in:
| Title: | Reply by Authors. |
|---|---|
| Authors: | Kaplan SA; Department of Urology, Icahn School of Medicine at Mount Sinai, New York City, New York., Herschorn S; Department of Surgery/Urology, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., McVary KT; Department of Urology, Stritch School of Medicine, Loyola University Medical Center, Maywood, Illinois., Staskin D; Division of Urology, St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts., Chapple C; Department of Urology, Royal Hallamshire Hospital, Sheffield, UK., Foley S; Department of Urology, Royal Berkshire Hospital, Reading, UK., Cambronero Santos J; Department of Urology, Infanta Leonor Hospital, Madrid, Spain., Kristy RM; Astellas Pharma Global Development Inc., Northbrook, Illinois., Choudhury N; Astellas Pharma Europe Ltd., Chertsey, UK., Hairston J; Astellas Pharma Global Development Inc., Northbrook, Illinois., Schermer CR; Astellas Pharma Global Development Inc., Northbrook, Illinois. |
| Source: | The Journal of urology [J Urol] 2020 Jun; Vol. 203 (6), pp. 1171. Date of Electronic Publication: 2020 Mar 19. |
| Publication Type: | Journal Article; Comment |
| Journal Info: | Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3792 (Electronic) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
